DDrare: Database of Drug Development for Rare Diseases

Clobetasol 0.05% topical ointment (DrugBank: Clobetasol)

4 diseases

ID	Disease name (Link within this page)	Number of trials
39	Toxic epidermal necrolysis	0
46	Malignant rheumatoid arthritis	0
51	Scleroderma	0
162	Pemphigoid	1

39. Toxic epidermal necrolysis [ 11 clinical trials, 18 drugs, (DrugBank: 8 drugs), 11 drug target genes, 101 drug target pathways]

Searched query = "Toxic epidermal necrolysis", "Toxic epidermal necrosis", "TEN"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.

0 / 11 trial found

46. Malignant rheumatoid arthritis [ 4,183 clinical trials, 2,538 drugs, (DrugBank: 401 drugs), 183 drug target genes, 219 drug target pathways]

Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.

0 / 4,183 trial found

51. Scleroderma [ 466 clinical trials, 536 drugs, (DrugBank: 142 drugs), 110 drug target genes, 210 drug target pathways]

Searched query = "Scleroderma", "Systemic sclerosis", "SSc", "dcSSc", "lcSSc"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.

0 / 466 trial found

162. Pemphigoid [ 70 clinical trials, 117 drugs, (DrugBank: 46 drugs), 30 drug target genes, 128 drug target pathways]

Searched query = "Pemphigoid", "Epidermolysis bullosa acquisita"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 70 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03286582 (ClinicalTrials.gov)	September 5, 2017	14/9/2017	A Proof-of-Concept Study of Topical AC-203 in Patients With Bullous Pemphigoid	A Randomized, Open-Label, Controlled Trial of Topical AC-203 in Subjects With Bullous Pemphigoid	Bullous Pemphigoid	Drug: AC-203 1% Topical Ointment;Drug: Clobetasol 0.05% Topical Ointment	TWi Biotechnology, Inc.	NULL	Terminated	20 Years	90 Years	All	10	Phase 2	Taiwan